How Much About Access to Care With “Skin Substitutes” is Around Cost (and Will the LCDs Actually Make That Better for Patients)?

How Much About Access to Care With “Skin Substitutes” is Around Cost (and Will the LCDs Actually Make That Better for Patients)?

A lot is being said about the way that the new LCD(s) around Cellular Tissue Products (CTPs) / skin substitutes might impact access to care. A big issue is around product choice and ensuring that there is a large enough suite of covered products from which physicians...
The US Cellular Tissue Product (CTP) / Skin Substitute Market Reached $1.75 Billion in the Third Quarter of 2023, Based on SmartTrak Analysis

The US Cellular Tissue Product (CTP) / Skin Substitute Market Reached $1.75 Billion in the Third Quarter of 2023, Based on SmartTrak Analysis

According to data obtained from SmartTrak Medical Device and Wound Market Intelligence, in the third quarter of 2024 (Q324), the US Skin Substitute / Cellular Tissue Product (CTP) market reached $1.75 BILLION. That figure is up 64.0% compared to the third quarter of...
Compared to the Third Quarter, the Cellular Tissue Product (CTP) / Skin Substitute Market Grew 64% in the Fourth Quarter of 2024

Compared to the Third Quarter, the Cellular Tissue Product (CTP) / Skin Substitute Market Grew 64% in the Fourth Quarter of 2024

According to data obtained from SmartTrak Medical Device and Wound Market Intelligence, in the fourth quarter of 2024 ( Q424), the US Cellular Tissue Product (CTP) / Skin Substitute market grew 64.0% over the third quarter of 2023 (Q323). Three market leaders combined...
“I’ve Consistently Been Told the Answer is Yes… At Least, I Hope it’s Yes — Otherwise, We’re All in Trouble.”

“I’ve Consistently Been Told the Answer is Yes… At Least, I Hope it’s Yes — Otherwise, We’re All in Trouble.”

Hi Dr. Fife, I’m sure you’re receiving plenty of feedback on this topic, but regarding your question about whether providers can receive discounts on ASP products, I’ve consistently been told the answer is yes… at least, I hope it’s yes—otherwise, we’re all in...
Why Aren’t Patients Up in Arms About Huge Copays for Cellular Tissue Products (CTPs) / Skin Substitutes?

Why Aren’t Patients Up in Arms About Huge Copays for Cellular Tissue Products (CTPs) / Skin Substitutes?

Last week I gave a talk at the Amputation Prevention Symposium entitled, “Elevate the CLI Patient’s Voice: Why it is so Important to do the Right Thing?” I have to confess that when the meeting organizers first asked me to explain why it’s important to do the...

According to Medicare Data Analyzed by SmartTRAK, Recent DOJ Prosecutions in the Cellular Tissue Product / Skin Substitute Market are the “Tip of the Iceberg”

Susan Paquette, the VP of the Wound division of SmartTRAK, recently posted an article on that company’s blog about the Cellular Tissue Product (CTP) / skin substitute industry. SmartTRAK provides market intelligence on industry trends and has been closely watching the...
Two Nurse Practitioners Charged in Connection with APX Scheme with Fraudulent Application of Amniotic Products

Two Nurse Practitioners Charged in Connection with APX Scheme with Fraudulent Application of Amniotic Products

District of Arizona | Seven Charged in Arizona as Part of the Department of Justice’s 2024 National Health Care Fraud Enforcement Action | United States Department of Justice The fallout continues from the indictments of Alexandra Gehrke and Jeffrey King on charges of...